Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled Phase II Clinical Study to Evaluate the Efficacy, Safety and Tolerability of JYB1904 Injection in Adult Patients with Chronic Spontaneous Urticaria Inadequately Controlled by H1 Antihistamines
Conditions
Interventions
JYB1904
JYB1904
+1 more
Locations
1
China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Start Date
August 4, 2024
Primary Completion Date
July 15, 2026
Completion Date
July 15, 2026
Last Updated
November 29, 2024
NCT07358364
NCT06931405
NCT06873516
NCT07230418
NCT07219615
NCT07021495
Lead Sponsor
Jemincare
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions